PFE – Pfizer Inc.
(39 Total) [click headers to sort columns]
| Symbol: | PFE |
| Last: | 15.00 |
| Date: | 7/30/2010 |
| Time: | 4:00pm |
| Change: | -0.09 |
| Open: | 15.02 |
| High: | 15.13 |
| Low: | 14.88 |
| Volume: | 44,041,100 |
| Date | RT | Stock | Group | Price | EPS | Sales (M) | Earnings % Chg | Sales % Chg | Earnings Rank | Strength Rank | PES | Avg Vol |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/05/10 | E | PFE – Pfizer Inc. | MED | 17.26 | .60/.54 | 16750 | +11.1 | +54+ | 5.4 | 2.0 | 29 | 66,752,000 |
| 02/04/10 | E | pfe – Pfizer Inc. | MED | 18.62 | .49/.65 | 16537 | -24.6 | +34 | 3.9 | 5.9 | 38 | 48,605,000 |
| 10/21/09 | E | pfe – Pfizer Inc. | MED | 17.93 | .51/.62 | 11621 | -17.7 | -2.9 | 4.6 | 3.1 | 35 | 50,189,000 |
| 07/23/09 | E | pfe – Pfizer Inc. | MED | 15.87 | .48/.55 | 10984 | -12.7 | -9.4 | 4.4 | 3.8 | 33 | 55,901,000 |
| 04/29/09 | E | pfe – Pfizer Inc. | MED | 13.39 | .54/.61 | 10867 | -11.5 | -8.3 | 6.5 | 2.7 | 25 | 66,791,000 |
| 01/27/09 | E | PFE – Pfizer Inc. | MED | 15.65 | .65/.50 | 12346 | +30.0+ | -4.1- | 7.2 | 6.5 | 24 | 53,189,000 |
| 10/22/08 | E | PFE – Pfizer Inc. | MED | 17.34 | .62/.58 | 11973 | +6.9- | -0.1- | 6.8 | 7.9 | 28 | 55,189,000 |
| 07/24/08 | EX3 | PFE – Pfizer Inc. | MED | 19.07 | .55/.42 | 12129 | +30.9+ | +9.4+ | 6.6 | 4.0 | 35 | 51,585,000 |
| 04/18/08 | E | pfe – Pfizer Inc. | MED | 20.40 | .61/.68 | 11848 | -10.3- | -5- | 5.9 | 3.3 | 33 | 42,128,000 |
| 01/24/08 | EX1 | PFE – Pfizer Inc. | MED | 22.89 | .52/.43 | 13065 | +20.9+ | +3.7+ | 6.8 | 6.3 | 44 | 42,491,000 |
| 10/19/07 | EX1 | PFE – Pfizer Inc. | MED | 24.54 | .58/.54 | 11990 | +7.4+ | -2.4+ | 4.9 | 3.6 | 42 | 41,295,000 |
| 07/19/07 | E | PFE – Pfizer Inc. | MED | 25.13 | .42/.50 | 11084 | -16- | -5.6- | 5.1 | 2.8 | 60 | 113,298,000 |
| 04/23/07 | EX1 | PFE – Pfizer Inc. | MED | 26.97 | .68/.59 | 12474 | +15.3+ | +6.2+ | 5.4 | 3.8 | 40 | 34,527,000 |
| 01/23/07 | E | pfe – Pfizer Inc. | MED | 26.95 | .43/.49 | 12603 | -12.2- | +2.5- | 4.9 | 4.6 | 63 | 44,367,000 |
| 10/20/06 | EX1 | PFE – Pfizer Inc. | MED | 27.68 | .56/.51 | 12280 | +9.8- | +9+ | 6.7 | 7.3 | 49 | 27,885,000 |
| 07/21/06 | EX1 | PFE – Pfizer Inc. | MED | 23.71 | .50/.45 | 11741 | +11.1- | +2.5+ | 7.0 | 4.5 | 47 | 26,261,000 |
| 04/20/06 | EX1 | PFE – Pfizer Inc. | MED | 24.82 | .61/.54 | 12660 | +13+ | -3.3+ | 5.2 | 2.6 | 41 | 27,474,000 |
| 01/20/06 | E | pfe – Pfizer Inc. | MED | 24.97 | .51/.58 | 13592 | -12.1- | -8.9- | 6.0 | 3.7 | 49 | 39,843,000 |
| 10/21/05 | E | pfe – Pfizer Inc. | MED | 21.90 | .51/.55 | 2189 | -7.3- | -5- | 6.2 | 1.4 | 43 | 26,213,000 |
| 07/21/05 | E | pfe – Pfizer Inc. | MED | 27.06 | .46/.47 | 12425 | -2.1- | +1.2- | 6.8 | 2.3 | 59 | 23,174,000 |
| 04/20/05 | E | PFE – Pfizer Inc. | MED | 27.42 | .54/.52 | 13091 | +3.9- | +4.8- | 8.1 | 3.8 | 51 | 30,057,000 |
| 01/20/05 | EX1 | PFE – Pfizer Inc. | MED | 24.88 | .58/.50 | 14924 | +16+ | +6.7+ | 8.8 | 0.7 | 43 | 39,452,000 |
| 10/21/04 | E | PFE – Pfizer Inc. | MED | 28.30 | .55/.48 | 12831 | +14.6- | +3.9- | 9.3 | 1.9 | 51 | 20,027,000 |
| 07/22/04 | E | PFE – Pfizer Inc. | MED | 32.00 | .47/.30 | 12274 | +56.7+ | +24- | 9.7 | 3.1 | 68 | 14,650,000 |
| 04/21/04 | E | PFE – Pfizer Inc. | MED | 36.70 | .52/.41 | 12487 | +26.8+ | +47- | 9.0 | 4.6 | 71 | 0 |
| 01/23/04 | E | PFE – Pfizer Inc. | MED | 36.14 | .52/.45 | 14167 | +15.6- | +52- | 9.3 | 3.2 | 70 | 18,563,000 |
| 10/23/03 | EX1 | PFE – Pfizer Inc. | MED | 30.62 | .47/.38 | 12504.0 | +23.7 | +56.4+ | 8.9 | 1.0 | 65 | 19,415,000 |
| 07/28/03 | EX1 | pfe – Pfizer Inc. | MED | 33.04 | .31/.33 | 9993.0 | -6- | +37+ | 8.4 | 3.1 | 107 | 19,614,000 |
| 04/23/03 | E | PFE – Pfizer Inc. | MED | 31.82 | .45/.39 | 8525.0 | +15- | +10- | 9.5 | 5.3 | 71 | 22,092,000 |
| 01/23/03 | EX3 | PFE – Pfizer Inc. | MED | 30.71 | .46/.32n | 9333.0 | +44+ | +14+ | 9.5 | 4.0 | 67 | 22,092,000 |
| 10/17/02 | EX1 | PFE – Pfizer Inc. | MED | 31.91 | .40/.35 | 8725.0 | +14+ | +12+ | 9.0 | 5.8 | 80 | 22,092,000 |
| 07/16/02 | E | PFE – Pfizer Inc. | MED | 28.78 | .33/.30d | 8033.0 | +10- | +5- | 9.1 | 2.5 | 87 | 21,292,000 |
| 04/18/02 | E | PFE – Pfizer Inc. | MED | 37.85 | .38/.31n | 8418.0 | +23- | +11- | 9.5 | 2.5 | 100 | 11,532,000 |
| 01/24/02 | EX1 | PFE – Pfizer Inc. | MED | 41.80 | .32/.23n | 9030.0 | +39- | +12+ | 9.6 | 4.1 | 131 | 11,544,000 |
| 10/18/01 | EX1 | PFE – Pfizer Inc. | MED | 41.65 | .33/.22n | 7898.0 | +50- | +10+ | 9.6 | 6.2 | 126 | 11,916,000 |
| 07/18/01 | EX1 | PFE – PFIZER INC | MED | 38.58 | .29/.18n | 7686.0 | +61 | +10+ | 9.5 | 3.5 | 133 | 12,109,000 |
| 04/19/01 | E | PFE – PFIZER INC | MED | 40.90 | .31/-.03n | 7645.0 | +7 | 9.2 | 5.4 | 132 | 14,254,000 | |
| 01/25/01 | EX1 | pfe – PFIZER INC | MED | 42.93 | .23/.24n | 8047.0 | -4- | +8+ | 9.0 | 5.4 | 187 | 13,505,000 |
| 01/19/00 | E | PFE – PFIZER INC | MED | 36.50 | .25/.08 | +213 | +17 | 9.3 | 3.7 | 146 | 12,597,000 | |
| Date | RT | Stock | Group | Price | EPS | Sales (M) | Earnings % Chg | Sales % Chg | ER | SR | PES | Avg Vol |